Mortality and years of potential life loss in systemic lupus erythematosus: A population-based cohort study

Lupus

Volumn 23, Issue 14, 2014, Pages 1546-1552

  Lerang, K ^a   Gilboe, I M ^a   Steinar Thelle, D ^b,c   Gran, J T ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

epidemiology; mortality; outcome; survival rate; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; AMERICAN; ARTICLE; CAUSE OF DEATH; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; AGE; AGED; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; INFECTION; KAPLAN MEIER METHOD; LIFE EXPECTANCY; LUNG DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MIDDLE AGED; NEOPLASM; NORWAY; SEX DIFFERENCE; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; INFECTION; KAPLAN-MEIER ESTIMATE; LIFE EXPECTANCY; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEOPLASMS; NORWAY; SEX FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84911087780     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314551083     Document Type: Article

References (27)

1. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus. Autoimmun Rev. 2004 ; 3: 423-453
2. Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 ; 380: 2071-2094
3. Abu-Shakra M, Novack V. Mortality and multiple causes of death in systemic lupus erythematosus - role of the death certificate. J Rheumatol. 2012 ; 39: 458-460
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
5. Gilboe IM, Husby G. Application of the 1982 revised criteria for the classification of systemic lupus erythematosus on a cohort of 346 Norwegian patients with connective tissue disease. Scand J Rheumatol. 1999 ; 28: 81-87
6. Lerang K, Gilboe IM, Gran JT. Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus. Rheumatology (Oxford). 2012 ; 51: 663-669
7. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
8. StatBank Norway. Statistics Norway, 2012, http://statbank.ssb.no//statistikkbanken/ (accessed August 2014).
9. Rothman KJ, Boice JD, National Cancer Institute (US), Environmental Epidemiology Branch, National Institutes of Health, Harvard University Dept. of Epidemiology. Epidemiologic analysis with a programmable calculator. Washington, DC: Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1979.
10. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol. 1997 ; 24: 1061-1065
11. Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 2152-2158
12. Voss A, Laustrup H, Hjelmborg J, Junker P. Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community. Lupus. 2013 ; 22: 1185-1191
13. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 2550-2557
14. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
15. Souza DC, Santo AH, Sato EI. Mortality profile related to systemic lupus erythematosus: A multiple cause-of-death analysis. J Rheumatol. 2012 ; 39: 496-503
16. Hochberg MC. Mortality from systemic lupus erythematosus in England and Wales, 1974-1983. Br J Rheumatol. 1987 ; 26: 437-441
17. Kaslow RA, Masi AT. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum. 1978 ; 21: 473-479
18. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: Relation to disease activity and damage accrual. Lupus. 2007 ; 16: 309-317
19. Gustafsson J, Gunnarsson I, Börjesson O, et al. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther. 2009 ; 11: R186 - R186
20. StatBank Norway, Dødelighetstabeller. Statistics Norway. 2005; http://www.ssb.no/a/kortnavn/dode/arkiv/tab-2006-04-27-05.html (accessed August 2014).
21. Teh CL, Ling GR. Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus. 2013 ; 22: 106-111
22. Heller T, Ahmed M, Siddiqqi A, Wallrauch C, Bahlas S. Systemic lupus erythematosus in Saudi Arabia: Morbidity and mortality in a multiethnic population. Lupus. 2007 ; 16: 908-914
23. Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curaçao: An epidemiological investigation. Ann Rheum Dis. 1992 ; 51: 1197-1201
24. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med. 1985 ; 55: 87-98
25. Gardner JW, Sanborn JS. Years of potential life lost (YPLL) - what does it measure?. Epidemiology. 1990 ; 1: 322-329
26. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003 ; 289: 187-193
27. Alfsen GC, Lyckander LG, Lindboe AW, Svaar H. Quality control of deaths in hospitals [article in Norwegian]. Tidsskr Nor Laegeforen. 2010 ; 130: 476-479